Joint Formulary & PAD

Rubefacients (excluding topical NSAIDs and capsaicin cream) - Pain

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Not Specified
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Rubefacients (excluding topical NSAIDs and capsaicin cream)
Indication :
Pain
Group Name :
Keywords :
low value medicines, drugs of low clinical value, LVM, drugs of limited clinical value, embrocation, heat wraps, soft tissue, topical pain relief, salicylic acid, salicylate, salicylatem benzydamine, nicotinate, menthol, camphor, birch oil, cajuput oil, eucalyptus oil, levomenthol, methoysmethane, acetic acid, turpentine oil, topical analgesia, topical analgesics
Brand Names Include :
Balmosa, Transvasin, Radian-B, Bell's Muscle Rub, Deep Heat, Tiger Balm, Mentholatum, Ralgex, Elliman's Universal Embrocation, Movelat, Algesal, Difflam Cream
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

The Prescribing Clinical Network does not recommend the use of rubefacients (excluding topical NSAIDs and capsaicin cream). Following link here to advice regarding capsaicin (Zacin) cream https://surreyccg.res-systems.net/pad/Search/DrugConditionProfile/6252

Rubefacients will be considered BLACK on the traffic light system prescribers should:

  • NOT initiate rubefacients for any new patient AND
  • De-prescribe rubefacients in all patients in line with NHS England guidance